As an adjunct in the short-term treatment of pain accompanied by tension and/or anxiety in patients with musculoskeletal disease. Clinical trials have demonstrated that in these situations relief of pain is somewhat greater than with aspirin alone. The effectiveness of Equagesic (meprobamate and aspirin) in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient

The usual dosage of Equagesic (meprobamate and aspirin) is one or two tablets, each tablet containing meprobamate, 200 mg, and aspirin, 325 mg, orally 3 to 4 times daily as needed for the relief of pain when tension or anxiety is present. Equagesic (meprobamate and aspirin) is not recommended for patients 12 years of age and under.

Equagesic (meprobamate and aspirin) ® (meprobamate with aspirin) Tablets, 200 mg meprobamate and 325 mg aspirin, are available as follows:

NDC 0008-0091, pink and yellow, double-layer, round, scored tablet marked "WYETH" and "91", in bottles of 100 tablets.

Store at room temperature, approx. 25^o C (77^o F). Keep tightly closed. Protect from light. Dispense in light-resistant, tight container.

Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.